Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility of Mesenchymal Stem Cells Therapy in Patients With Recent Intracerebral Hemorrhage

NCT03371329 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03371329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03371329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility of Mesenchymal Stem Cells Therapy in Patients With Recent Intracerebral Hemorrhage
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
December 12, 2017
Completion date
October 9, 2020
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhagic stroke, intracerebral hemorrhage